Chemoinformaics analysis of Glycerides, C14-18
| Molecular Weight | 288.428 | nRot | 14 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 22 |
| Exact Molecular Weight | 288.23 | nRing | 0 |
| Solubility: LogS | -6.435 | nHRing | 0 |
| Solubility: LogP | 6.406 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 51.2654 |
| nHD | 2 | BPOL | 34.7066 |
| QED | 0.439 |
| Synth | 4.509 |
| Natural Product Likeliness | 2.407 |
| NR-PPAR-gamma | 0.103 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.879 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.936 |
| MDCK | 0.0000095 |
| BBB | 0.973 |
| PPB | 0.983153 |
| VDSS | 1.448 |
| FU | 0.0147309 |
| CYP1A2-inh | 0.039 |
| CYP1A2-sub | 0.556 |
| CYP2c19-inh | 0.073 |
| CYP2c19-sub | 0.945 |
| CYP2c9-inh | 0.11 |
| CYP2c9-sub | 0.377 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.574 |
| CYP3a4-inh | 0.162 |
| CYP3a4-sub | 0.675 |
| CL | 20.42 |
| T12 | 0.059 |
| hERG | 0.039 |
| Ames | 0.018 |
| ROA | 0.268 |
| SkinSen | 0.039 |
| Carcinogencity | 0.018 |
| EI | 0.009 |
| Respiratory | 0.891 |
| NR-Aromatase | 0.016 |
| Antiviral | Yes |
| Prediction | 0.721788 |